Title:
Ventricular Assist Device Market: (Product Type - Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Bi-Ventricular Assist Device (Bi-VAD), and Total Artificial Heart (TAH); Indication - Bridge To Transplant (BTT), Destination Therapy (DT), and Bridge To Recovery (BTR)) - North America Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.
North America Ventricular Assist Device Market: Overview
Advance Heart Failure is characterized as weakening of the heart caused due to failure of the left ventricle, due to which the heart is unable to pump blood to different parts of the body. According to the AHA (American Heart Association), 5.7 Mn people in the U.S suffer from heart failure and 300,000 die each year of heart failure. Moreover, the AHA predicts that advance heart failure will become the most common cause of death globally. However, these statistics have already materialized in the U.S. and Canada, where advance heart failure is currently said to be the leading cause of mortality. In Canada, the figures are rising day by day. In Canada nearly 600,000 of the total is affected by heart failure. A large proportion of these population can be saved with proper treatment and care. Thus, the existence of an unmet medical need is clearly evident and is anticipated to augment the ventricular assist device market.
North America Ventricular Assist Device Market: Scope of the Study
This report on the ventricular assist device market in the North America analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2014 to 2024 are provided for all the segments, considering 2015 as the base year. Market related factors such as technological developments, patent expiry, recent approvals, investment in clinical studies and acquisitions by leading players in the market, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the North America ventricular assist device market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, drug development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the ventricular assist device market in North America.
North America Ventricular Assist Device Market: Segmentation
Based on product type, the North America ventricular assist device market has been segmented into Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), Biventricular Assist Device (Bi-VAD) and total artificial heart (TAH).
Based on indication, the North America ventricular assist device market has been segmented into bridge to transplant (BTT), destination therapy (DT) and bridge to recovery (BTR). The American Heart Association reported that 2.6% of the total population is suffering from cardiovascular disease and heart failure is the leading cause of death in the U.S. and around 1.6% in Canada suffer from heart failure, and the number is rising each year. Therefore consequently driving the ventricular assist device market in North America during the forecast period.
North America Ventricular Assist Device Market: Geographical Outlook
Geographically, the North America ventricular assist device market has been segmented into two countries: the U.S. and Canada. These countries have been further segmented by indication and product type. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the ventricular assist device market in North America.
Companies Mentioned in the Report
The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include ABIOMED, St. Jude Medical, HeartWare, SynCardia Systems LLC, Sunshine Heart, Inc., Berlin Heart GmbH
The North America ventricular assist device market has been segmented as follows:
North America Ventricular Assist Device Market, by Product Type
- LVAD (Left ventricular assist device)
- RVAD (Right ventricular assist device)
- Bi-VAD (Biventricular assist device)
- TAH( Total artificial heart)
North America Ventricular Assist Device Market, by Indication
- BTT (Bridge To Transplant)
- DT (Destination Therapy)
- BTR (Bridge To Recovery)
Table of Contents
Chapter 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: North America Ventricular Assist Device Market
Chapter 4. Market Overview
- 4.1. Introduction
- 4.2. Key Industry Developments
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunity
- 4.4. Porter's Five Forces Analysis
Chapter 5. North America Ventricular Assist Device Market Analysis and Forecast, By Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.3. Market Size (US$ Mn) Forecast, by Product Type
- 5.3.1. Left Ventricular Assist Device (LVAD)
- 5.3.2. Right Ventricular Assist Device (RVAD)
- 5.3.3. Biventricular Assist Device (Bi-VAD)
- 5.3.4. Total Artificial Heart (TAH)
- 5.4. Market Attractiveness Analysis, by Product Type, 2015
- 5.5. Key Trends
Chapter 6. North America Ventricular Assist Device Market Analysis and Forecast, By Indication
- 6.1. Key Findings
- 6.2. Introduction
- 6.3. Market Size (US$ Mn) Forecast, by Indication
- 6.3.1. Bridge to Transplant (BTT)
- 6.3.2. Destination therapy (DT)
- 6.3.3. Bridge to Recovery (BTR)
- 6.4. Market Attractiveness Analysis, by Indication, 2014
- 6.5. Key Trends
Chapter 7. North America Ventricular Assist Device Market Analysis and Forecast, By Region
- 7.1. Market Scenario
- 7.2. Introduction
- 7.3. Market Size (US$ Mn) Forecast, by Region
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Market Attractiveness Analysis, by Region, 2015
Chapter 8. U.S. Ventricular Assist Device Market Analysis and Forecast
- 8.1. Key Findings
- 8.2. Introduction
- 8.3. Market Size (US$ Mn) Forecast, by Product Type
- 8.3.1. LVAD
- 8.3.2. RVAD
- 8.3.3. Bi-VAD
- 8.3.4. TAH
- 8.4. Market Size (US$ Mn) Forecast, by Indication
- 8.4.1. BTT
- 8.4.2. DT
- 8.4.3. BTR
- 8.5. Market Attractiveness Analysis, by Product Type, 2015
- 8.6. Market Attractiveness Analysis, by Indication, 2015
- 8.7. Key Trends
Chapter 9. Canada Ventricular Assist Device Market Analysis and Forecast
- 9.1. Key Findings
- 9.2. Introduction
- 9.3. Market Size (US$ Mn) Forecast, by Product Type
- 9.3.1. LVAD
- 9.3.2. RVAD
- 9.3.3. Bi-VAD
- 9.3.4. TAH
- 9.4. Market Size (US$ Mn) Forecast, by Indication
- 9.4.1. BTT
- 9.4.2. DT
- 9.4.3. BTR
- 9.5. Market Attractiveness Analysis, by Product Type, 2015
- 9.6. Market Attractiveness Analysis, by Indication, 2015
- 9.7. Key Trends
Chapter 10. Competition Landscape
- 10.1. North America Ventricular Assist Device Market Share Analysis, Key Players, 2015
- 10.2. Competition Matrix
- 10.3. Company Profiles
- 10.3.1. ABIOMED
- 10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 10.3.1.2. Financial Overview
- 10.3.1.3. Product Portfolio
- 10.3.1.4. SWOT Analysis
- 10.3.1.5. Strategic Overview
- 10.3.2. Heart Ware International Inc.
- 10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 10.3.2.2. Financial Overview
- 10.3.2.3. Product Portfolio
- 10.3.2.4. SWOT Analysis
- 10.3.2.5. Strategic Overview
- 10.3.3. St. Jude Medical
- 10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 10.3.3.2. Financial Overview
- 10.3.3.3. Product Portfolio
- 10.3.3.4. SWOT Analysis
- 10.3.4. SUNSHINE HEART, Inc.
- 10.3.4.1. Company Overview (HQ, business segments, employee strength)
- 10.3.4.2. Financial Overview
- 10.3.4.3. Product Portfolio
- 10.3.4.4. SWOT Analysis
- 10.3.4.5. Strategic Overview
- 10.3.5. SynCardia Systems, LLC.
- 10.3.5.1. Company Overview (HQ, business segments, employee strength)
- 10.3.5.2. Product Portfolio
- 10.3.5.3. SWOT Analysis
- 10.3.5.4. Recent Developments
- 10.3.5.5. Strategic Overview
- 10.3.6. Berlin Heart GmbH
- 10.3.6.1. Company Overview (HQ, business segments, employee strength)
- 10.3.6.2. Financial Overview
- 10.3.6.3. Product Portfolio
- 10.3.6.4. SWOT Analysis
- 10.3.6.5. Strategic Overview
List of Figures
- Figure 1: North America Ventricular Assist Device Market Size (US$ Mn), 2014-2024
- Figure 2: North America Ventricular Assist Device Market Value Share Analysis, by Product Type, 2014 and 2024
- Figure 3: North America LVAD Market Revenue (US$ Mn), 2014-2024
- Figure 4: North America RVAD Market Revenue (US$ Mn), 2014-2024
- Figure 5: North America Bi-VAD Market Revenue (US$ Mn), 2014-2024
- Figure 6: North America TAH Market Revenue (US$ Mn), 2014-2024
- Figure 7: North America Ventricular Assist Device Attractiveness Analysis, by Product Type, 2015
- Figure 8: North America Ventricular Assist Device Value Share Analysis, by Indication, 2014 and 2024
- Figure 9: North America BTT Market Revenue (US$ Mn), 2014-2024
- Figure 10: North America DT Market Revenue (US$ Mn), 2014-2024
- Figure 11: North America BTR Market Revenue (US$ Mn), 2014-2024
- Figure 12: North America Ventricular Assist Device Attractiveness Analysis, by Indication, 2015
- Figure 13: North America Ventricular Assist Device Value Share Analysis, by Region, 2014 and 2024
- Figure 14: North America Ventricular Assist Device Attractiveness Analysis, by Region, 2015
- Figure 15: U.S. Ventricular Assist Device Market Size (US$ Mn), 2014-2024
- Figure 16: U.S. Ventricular Assist Device Market Y-o-Y Growth Projections, 2015-2024
- Figure 17: U.S. Market Value Share Analysis, by Product Type, 2014 and 2024
- Figure 18: U.S. Market Value Share Analysis, by Indication, 2014 and 2024
- Figure 19: U.S. Ventricular Assist Device Market Analysis and Forecast, US$ Mn, by Product Type, 2014- 2024
- Figure 20: U.S. Ventricular Assist Device Market Analysis and Forecast, US$ Mn, by Indication, 2014-2024
- Figure 21: U.S. Ventricular Assist Device Market Attractiveness Analysis, by Product Type, 2015
- Figure 22: U.S. Ventricular Assist Device Market Attractiveness Analysis, by Indication, 2015
- Figure 23: Canada Ventricular Assist Device Market Size (US$ Mn), 2014-2024
- Figure 24: Canada Ventricular Assist Device Market Y-o-Y Growth Projections, 2015-2024
- Figure 25: Canada Market Value Share Analysis, by Product Type, 2014 and 2024
- Figure 26: Canada Market Value Share Analysis, by Indication, 2014 and 2024
- Figure 27: Canada Ventricular Assist Device Market Analysis and Forecast, US$ Mn, by Product Type, 2014-2024
- Figure 28: Canada Ventricular Assist Device Market Analysis and Forecast, US$ Mn, by Indication, 2014-2024
- Figure 29: Canada Ventricular Assist Device Market Attractiveness Analysis, by Product Type, 2015
- Figure 30: Canada Ventricular Assist Device Market Attractiveness Analysis, by Indication, 2015
- Figure 31: North America Ventricular Assist Device Market Share Analysis, by Company (2015)
List of Tables
- Table 1: North America Ventricular Assist Device Market Size Analysis and Forecast (US$ Mn), by Product Type, 2014-2024
- Table 2: North America Ventricular Assist Device Market Size Analysis and Forecast (US$ Mn), by Indication, 2014-2024
- Table 3: North America Ventricular Assist Device Market Size Analysis and Forecast (US$ Mn), by Region, 2014-2024
- Table 4: U.S. Ventricular Assist Device Market Size Analysis and Forecast (US$ Mn), by Product Type, 2014-2024
- Table 5: U.S. Ventricular Assist Device Market Size Analysis and Forecast (US$ Mn), by Indication Type, 2014-2024
- Table 6: Canada Ventricular Assist Device Market Size Analysis and Forecast (US$ Mn), by Product Type, 2014-2024
- Table 7: Canada Ventricular Assist Device Market Size Analysis and Forecast (US$ Mn), by Indication, 2014-2024
輔助人工心臟(VAD)的全球市場:各產品(左室輔助設備、右室輔助設備、兩心輔助設備)、運行原理(拍動流VAD、定動流VAD)、用途 2019年∼2025年
輔助人工心臟(VAD)的全球市場:2020年∼2024年
輔助人工心臟的全球市場
輔助人工心臟(VAD)的全球市場 - 成長，趨勢，預測(2019年∼2024年)
輔助人工心臟 (VAD)、全人工心臟 (TAH)的全球市場:產品、流通管道、地區資料 - 分析與預測 (2019-2023年)
心室輔助裝置 (VAD)的全球市場:未來展望
輔助人工心臟(VAS)的全球市場預測:產品種類(左室·右室，兩心室補助)，各地區
輔助人工心臟 (VAD):醫療設備的開發平台評估
輔助人工心臟 (VAD)的全球市場 2017-2027年:各產品 (LAVD、RVAD、BiVAD)、用途 (BTT&BTD治療、DT、BTR治療)、地區的收益預測
